Jefferies Sticks to Their Buy Rating for Clarity Pharmaceuticals Ltd. (CU6)

TipRanksJul 14 08:16 ET

Clarity Pharmaceuticals Target Price Raised 97% to A$6.10/Share by Jefferies>CU6.AU

Clarity Pharmaceuticals Target Price Raised 97% to A$6.10/Share by Jefferies>CU6.

Dow JonesJul 11 18:13 ET

3 ASX Small-cap Shares That Soared 250% to 675% in FY24

The S&P/ASX All Ordinaries Index (ASX: XAO) moved 8.27% higher in FY24, which is a perfectly respectable return.

The Motley FoolJul 9 18:25 ET

5 ASX All Ords Shares That Rose 250% to 700% in FY24

While past performance is never a guarantee of future performance, let's take a look at some of the ASX All Ords shares that went gangbusters in FY24, delivering some mesmerising share price gains.

The Motley FoolJul 4 07:05 ET

Clarity Pharmaceuticals Receives AU$10 Million R&D Tax Refund

Clarity Pharmaceuticals (ASX:CU6) received about AU$10 million in research and development refund as part of the Australian government's tax incentive program, according to a Monday filing with the Au

MT NewswiresJun 24 17:29 ET

Why Clarity Pharmaceuticals, Life360, Ramsay Health Care, and Spartan Resources Shares Are Rising Today

The S&P/ASX 200 Index (ASX: XJO) is having a subdued session on Tuesday and is trading slightly lower. In afternoon trade, the benchmark index is down 0.1% to 7,754.1 points.

The Motley FoolJun 3 22:51 ET